ErbB signaling and cell cycle pathways associated with trastuzumab deruxtecan resistance in HER2-positive metastatic breast cancer: a case report.

Saved in:
Bibliographic Details
Title: ErbB signaling and cell cycle pathways associated with trastuzumab deruxtecan resistance in HER2-positive metastatic breast cancer: a case report.
Authors: Gao HF; Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China., Lin YY; Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.; School of Medicine, South China University of Technology, Guangzhou, China., Lv XZ; Burning Rock Biotech Ltd., Guangzhou, China., Li H; Biomedical Laboratory, Jingke BioTech Group, Guangzhou, China., Xu FP; Department of Pathology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China., Wang K; Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
Source: AME case reports [AME Case Rep] 2025 Sep 29; Vol. 9, pp. 118. Date of Electronic Publication: 2025 Sep 29 (Print Publication: 2025).
Publication Type: Case Reports; Journal Article
Journal Info: Publisher: AME Publishing Company Country of Publication: China NLM ID: 101730832 Publication Model: eCollection Cited Medium: Internet ISSN: 2523-1995 (Electronic) Linking ISSN: 25231995 NLM ISO Abbreviation: AME Case Rep Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41210453
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: ErbB signaling and cell cycle pathways associated with trastuzumab deruxtecan resistance in HER2-positive metastatic breast cancer: a case report.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Gao+HF%22">Gao HF</searchLink>; Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Lin+YY%22">Lin YY</searchLink>; Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.; School of Medicine, South China University of Technology, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Lv+XZ%22">Lv XZ</searchLink>; Burning Rock Biotech Ltd., Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Li+H%22">Li H</searchLink>; Biomedical Laboratory, Jingke BioTech Group, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Xu+FP%22">Xu FP</searchLink>; Department of Pathology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.<br /><searchLink fieldCode="AU" term="%22Wang+K%22">Wang K</searchLink>; Department of Breast Cancer, Cancer Center, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101730832%22">AME case reports</searchLink> [AME Case Rep] 2025 Sep 29; Vol. 9, pp. 118. <i>Date of Electronic Publication: </i>2025 Sep 29 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Case Reports; Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22AME+Publishing+Company%22">AME Publishing Company </searchLink><i>Country of Publication: </i>China <i>NLM ID: </i>101730832 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2523-1995 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2225231995%22">25231995 </searchLink><i>NLM ISO Abbreviation: </i>AME Case Rep <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41210453
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.21037/acr-2025-118
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 118
    Titles:
      – TitleFull: ErbB signaling and cell cycle pathways associated with trastuzumab deruxtecan resistance in HER2-positive metastatic breast cancer: a case report.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Gao HF
      – PersonEntity:
          Name:
            NameFull: Lin YY
      – PersonEntity:
          Name:
            NameFull: Lv XZ
      – PersonEntity:
          Name:
            NameFull: Li H
      – PersonEntity:
          Name:
            NameFull: Xu FP
      – PersonEntity:
          Name:
            NameFull: Wang K
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 29
              M: 09
              Text: 2025 Sep 29
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2523-1995
          Numbering:
            – Type: volume
              Value: 9
          Titles:
            – TitleFull: AME case reports
              Type: main
ResultId 1